Company profile
Bot Verification
Caldan Therapeutics Limited is a UK company with status active founded in 2015 based in Scotland.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AD01 | Transaction MzQ0MjM1ODQ0NmFkaXF6a2N4 | Paper/PDF filed
Published 08 Nov 2024 01:04
RESOLUTIONS | Transaction QURDSVZJQjZhZGlxemtjeA | Paper/PDF filed
Published 02 Oct 2024 06:37
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Caldan Therapeutics Ltd is a spin out company based in Edinburgh and established by myself and my academic co-founder Professor Trond Ulven of the University of Southern Denmark (now at University of Copenhagen) . The company is centred on the development of new therapeutics to treat type II diabetes and NASH by targeting the G protein-coupled receptors for long chain free fatty acids. Caldan Therapeutics initially (2015) raised £4.45 million of Series A funding to drive this venture and in 2019 as further £2 million was raised to support the research programme.
Caldan Therapeutics is developing a new treatment for Type-2 diabetes.
None to date
